These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8098116)

  • 1. Photosensitivity due to ambulatory intravenous ceftazidime in cystic fibrosis patient.
    Vinks SA; Heijerman HG; de Jonge P; Bakker W
    Lancet; 1993 May; 341(8854):1221-2. PubMed ID: 8098116
    [No Abstract]   [Full Text] [Related]  

  • 2. Does monotherapy of pulmonary infections in cystic fibrosis lead to early development of resistant strains of Pseudomonas aeruginosa?
    Watkins J; Francis J; Kuzemko JA
    Scand J Gastroenterol Suppl; 1988; 143():81-5. PubMed ID: 3133756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ceftazidime in cystic fibrosis: clinical, microbiological and immunological studies.
    Cullen RT; McCrae WM; Govan J; Raeburn JA; Ingram TM
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():369-75. PubMed ID: 6352647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experience with ceftazidime in cystic fibrosis.
    Dodge J; Zamiri I; Goodchild M; Ingram P
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():325-9. PubMed ID: 6352637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ceftazidime - a significant advance in the treatment of cystic fibrosis.
    David TJ; Phillips BM; Connor PJ
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():337-40. PubMed ID: 6352639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ceftazidime treatment of chronic Pseudomonas infection in patients with cystic fibrosis.
    Fluge G; Digranes A; Michalsen H; Stiris T; Bergan T; Qvigstad EK
    Eur J Respir Dis; 1987 Oct; 71(4):239-43. PubMed ID: 3319661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Photosensitivity associated with ciprofloxacin use in adult patients with cystic fibrosis.
    Burdge DR; Nakielna EM; Rabin HR
    Antimicrob Agents Chemother; 1995 Mar; 39(3):793. PubMed ID: 7793897
    [No Abstract]   [Full Text] [Related]  

  • 8. Intravenous desensitization to ceftazidime in cystic fibrosis patients.
    Ghosal S; Taylor CJ
    J Antimicrob Chemother; 1997 Apr; 39(4):556-7. PubMed ID: 9145836
    [No Abstract]   [Full Text] [Related]  

  • 9. Alternative antibiotics for the treatment of Pseudomonas infections in cystic fibrosis.
    Mastella G; Agostini M; Barlocco G; Bonomi U; Borgo G; Bozzino L; Cabrini G; Cappelletti LM; Castellani L; Conforti M
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():297-311. PubMed ID: 6311788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical pharmacology of ceftazidime in paediatrics.
    Assael BM; Boccazzi A; Caccamo ML; Giunta A; Marini A; Padoan R; Rusconi F; Sereni F
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():341-6. PubMed ID: 6352640
    [No Abstract]   [Full Text] [Related]  

  • 11. Ceftazidime in cystic fibrosis: pharmacokinetics and therapeutic response.
    Kercsmar CM; Stern RC; Reed MD; Myers CM; Murdell D; Blumer JL
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():289-95. PubMed ID: 6352634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. To the editor: Is it safe to administer a continuous infusion of ceftazidime (Fortum) prepared for 24 hours in cystic fibrosis (CF) patients?
    Plasse JC; Chabloz C; Terrier A; Bellon G
    Pediatr Pulmonol; 2002 Mar; 33(3):232-3. PubMed ID: 11836805
    [No Abstract]   [Full Text] [Related]  

  • 13. Ceftazidime alone and in combination in patients with cystic fibrosis: lack of efficacy in treatment of severe respiratory infections caused by Pseudomonas cepacia.
    Gold R; Jin E; Levison H; Isles A; Fleming PC
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():331-6. PubMed ID: 6352638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical results and pharmacokinetics of ceftazidime treatment in patients with cystic fibrosis.
    Strandvik B; Malmborg AS; Alfredson H; Ericsson A
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():283-7. PubMed ID: 6352633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of pyocyanic bacillus superinfections in children with cystic fibrosis using a new cephalosporin: ceftazidime].
    Labbé A; Sablayrolles B; Dechamps C; Sirot J; Marty N
    Ann Pediatr (Paris); 1986 Sep; 33(7):625-8. PubMed ID: 3096185
    [No Abstract]   [Full Text] [Related]  

  • 16. Ceftazidime treatment of chronic Pseudomonas aeruginosa respiratory tract infection in cystic fibrosis.
    Permin H; Koch C; Høiby N; Christensen HO; Møller AF; Møller S
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():313-23. PubMed ID: 6352636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An open study of the use of ceftazidime in Gram-negative infections.
    Wardle JK; Snow MH; Ingham HR; Selkon JB
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():389-93. PubMed ID: 6352650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cystic fibrosis: intravenous treatment at home.
    Catchpole A
    Nurs Times; 1989 Mar 22-28; 85(12):40-2. PubMed ID: 2717454
    [No Abstract]   [Full Text] [Related]  

  • 19. [Intravenous administration of antibiotics in the treatment of cystic fibrosis].
    Vávrová V; Lochmann O; Suková B; Copová M; Zapletal A; Absolonová V; Houstĕk J
    Cesk Pediatr; 1986 Oct; 41(10):605-7. PubMed ID: 3502950
    [No Abstract]   [Full Text] [Related]  

  • 20. [Tolerance and efficacy of ceftazidime in combination with aztreonam for exacerbations of cystic fibrosis].
    Prévotat A; Leroy S; Perez T; Wallet F; Wallaert B
    Rev Mal Respir; 2010 May; 27(5):449-56. PubMed ID: 20569877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.